Proposed Collection; 60-Day Comment Request: Clearance for Surveys of Customers and Partners of the Office of Extramural Research of the National Institutes of Health, 70062-70063 [2013-27965]
Download as PDF
<![CDATA[
70062
Federal Register / Vol. 78, No. 226 / Friday, November 22, 2013 / Notices
Families is soliciting public comment
on the specific aspects of the
information collection described above.
Copies of the proposed collection of
information can be obtained and
comments may be forwarded by writing
to the Administration for Children and
Families, Office of Planning, Research
and Evaluation, 370 L’Enfant
Promenade SW., Washington, DC 20447,
Attn: ACF Reports Clearance Officer.
Email address: infocollection@
acf.hhs.gov. All requests should be
identified by the title of the information
collection.
The Department specifically requests
comments on: (a) Whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
the quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Consideration will be given to
comments and suggestions submitted
within 60 days of this publication.
Rockville, MD 20855, 240–276–9079,
john.bartkowiak@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Zoetis
Inc., 333 Portage St., Kalamazoo, MI
49007, has requested that FDA
withdraw approval of the following
three NADAs because the products,
used to manufacture Type B and Type
C medicated feeds, are no longer
manufactured or marketed: NADA 007–
891 for 3–NITRO (roxarsone) Type A
medicated article, NADA 092–953 for
Roxarsone Type A Medicated Articles,
and NADA 010–285 for CARB–O–SEP
(carbarsone) Type A medicated article.
Therefore, under authority delegated
to the Commissioner of Food and Drugs
and redelegated to the Center for
Veterinary Medicine, and in accordance
with § 514.116 Notice of withdrawal of
approval of application (21 CFR
514.116), notice is given that approval
of NADAs 007–891, 092–953, and 010–
285, and all supplements and
amendments thereto, is hereby
withdrawn.
Elsewhere in this issue of the Federal
Register, FDA is amending the animal
drug regulations to reflect the voluntary
withdrawal of approval of these
applications.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 2013–27916 Filed 11–21–13; 8:45 am]
Dated: November 18, 2013.
Bernadette Dunham,
Director, Center for Veterinary Medicine.
BILLING CODE 4160–01–P
[FR Doc. 2013–28062 Filed 11–21–13; 8:45 am]
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Food and Drug Administration
[Docket No. FDA–2013–N–0002]
Withdrawal of Approval of New Animal
Drug Applications; Carbarsone;
Roxarsone
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is withdrawing
approval of three new animal drug
applications (NADAs) for roxarsone or
carbarsone Type A medicated articles at
the sponsor’s request because the
products are no longer manufactured or
marketed.
DATES: Withdrawal of approval is
effective December 2, 2013.
FOR FURTHER INFORMATION CONTACT: John
Bartkowiak, Center for Veterinary
Medicine (HFV–212), Food and Drug
Administration, 7519 Standish Pl.,
emcdonald on DSK67QTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
16:47 Nov 21, 2013
Jkt 232001
Proposed Collection; 60-Day Comment
Request: Clearance for Surveys of
Customers and Partners of the Office
of Extramural Research of the National
Institutes of Health
In compliance with the
requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
for opportunity for public comment on
proposed data collection projects, the
Office of Extramural Research (OER),
the National Institutes of Health (NIH)
will publish periodic summaries of
proposed projects to be submitted to the
Office of Management and Budget
(OMB) for review and approval.
Written comments and/or suggestions
from the public and affected agencies
are invited on one or more of the
following points: (1) Whether the
proposed collection of information is
necessary for the proper performance of
the function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
SUMMARY:
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimize the
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
To submit comments in writing,
request more information on the
proposed project, or to obtain a copy of
the data collection plans and
instruments, contact Dr. Sherry Mills,
Director, Office of Extramural Programs,
OER, NIH, 6705 Rockledge Drive, Suite
350, Bethesda, MD 20892, or call nontoll-free number (301) 435–2729, or
Email your request, including your
address to: OEPMailbox@mail.nih.gov.
Comments regarding this information
collection are best assured of having
their full effect if received within 60days of the date of this publication.
Proposed Collection: Generic
Clearance for Surveys of Customers and
Partners of the Office of Extramural
Research of the National Institutes of
Health—Extension—0925–0627—Office
of the Director (OD), Office of
Extramural Research (OER), Office of
Extramural Programs (OEP), National
Institutes of Health (NIH).
Need and Use of Information
Collection: OER develops, coordinates
the implementation of, and evaluates
NIH-wide policies and procedures for
the award of extramural funds. To move
forward with our initiatives to ensure
success in accomplishing the NIH
mission, input from partners and
customers is essential. Quality
management principles have been
integrated into OER’s culture and these
surveys will provide customer
satisfaction input on various elements of
OER’s business processes. The
approximately 14 (10 quantitative and 4
qualitative) customer satisfaction
surveys that will be conducted under
this generic clearance will gather and
measure customer and partner
satisfaction with OER processes and
operations. The data collected from
these surveys will provide the feedback
to track and gauge satisfaction with
NIH’s statutorily mandated operations
and processes. OER/OD/NIH will
present data and outcomes from these
surveys to inform the NIH staff, officers,
leadership, advisory committees, and
other decision-making bodies as
appropriate. Based on feedback from
these stakeholders, OER/OD/NIH will
E:\FR\FM\22NON1.SGM
22NON1
70063
Federal Register / Vol. 78, No. 226 / Friday, November 22, 2013 / Notices
formulate improvement plans and take
action when necessary.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
2,485.
Estimated Annualized Burden Hours
QUANTITATIVE SURVEY
Number of
respondents
Type of respondent
Science professionals, applicants, reviewers, Institutional Officials ................
Adult Science Trainees ....................................................................................
General Public .................................................................................................
Number of
responses per
respondent
3,820
2,000
4,000
1
1
1
Average
burden per
response
(in hours)
Total annual
burden hour
15/60
15/60
15/60
955
500
1,000
QUALITATIVE SURVEY
Number of
respondents
Type of respondent
Science professionals, applicants, reviewers, Institutional Officials ................
Adult Science Trainees ....................................................................................
General Public .................................................................................................
Dated: November 13, 2013.
Seleda Perryman,
Chief, Project Clearance Officer, Office of
Policy for Extramural Research
Administration, National Institutes of Health.
[FR Doc. 2013–27965 Filed 11–21–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
emcdonald on DSK67QTVN1PROD with NOTICES
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; NIDDK Career
Awards Review.
Date: December 4, 2013.
Time: 4:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Mar<15>2010
16:47 Nov 21, 2013
Jkt 232001
12
6
12
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Carol J. Goter-Robinson,
Ph.D., Scientific Review Officer, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 748, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)
594–7791, goterrobinsonc@
extra.niddk.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Time-Sensitive
Obesity.
Date: December 11, 2013.
Time: 3:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Michele L. Barnard, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 753, 6707 Democracy Boulevard,
Bethesda, MD 20892–2542, (301) 594–8898,
barnardm@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: November 18, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–28003 Filed 11–21–13; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
1
1
1
Average
burden per
response
(in hours)
Total annual
burden hour
1
1
1
12
6
12
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Board
of Scientific Counselors, National
Human Genome Research Institute.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
NATIONAL HUMAN GENOME
RESEARCH INSTITUTE, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, National Human Genome
Research Institute.
Date: December 11–13, 2013.
Time: 6:00 p.m. to 1:00 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Building 45, Room D, 9000 Rockville Pike,
Rockville, MD 20892.
Contact Person: Monica Berger, Executive
Secretary, Office of the Scientific Director,
National Human Genome Research Institute,
50 South Drive, Bldg. 50, Rm. 5222,
E:\FR\FM\22NON1.SGM
22NON1
]]>Agencies
[Federal Register Volume 78, Number 226 (Friday, November 22, 2013)]
[Notices]
[Pages 70062-70063]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-27965]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment Request: Clearance for
Surveys of Customers and Partners of the Office of Extramural Research
of the National Institutes of Health
SUMMARY: In compliance with the requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995, for opportunity for public comment
on proposed data collection projects, the Office of Extramural Research
(OER), the National Institutes of Health (NIH) will publish periodic
summaries of proposed projects to be submitted to the Office of
Management and Budget (OMB) for review and approval.
Written comments and/or suggestions from the public and affected
agencies are invited on one or more of the following points: (1)
Whether the proposed collection of information is necessary for the
proper performance of the function of the agency, including whether the
information will have practical utility; (2) The accuracy of the
agency's estimate of the burden of the proposed collection of
information, including the validity of the methodology and assumptions
used; (3) Ways to enhance the quality, utility, and clarity of the
information to be collected; and (4) Ways to minimize the burden of the
collection of information on those who are to respond, including the
use of appropriate automated, electronic, mechanical, or other
technological collection techniques or other forms of information
technology.
To submit comments in writing, request more information on the
proposed project, or to obtain a copy of the data collection plans and
instruments, contact Dr. Sherry Mills, Director, Office of Extramural
Programs, OER, NIH, 6705 Rockledge Drive, Suite 350, Bethesda, MD
20892, or call non-toll-free number (301) 435-2729, or Email your
request, including your address to: OEPMailbox@mail.nih.gov.
Comments regarding this information collection are best assured of
having their full effect if received within 60-days of the date of this
publication.
Proposed Collection: Generic Clearance for Surveys of Customers and
Partners of the Office of Extramural Research of the National
Institutes of Health--Extension--0925-0627--Office of the Director
(OD), Office of Extramural Research (OER), Office of Extramural
Programs (OEP), National Institutes of Health (NIH).
Need and Use of Information Collection: OER develops, coordinates
the implementation of, and evaluates NIH-wide policies and procedures
for the award of extramural funds. To move forward with our initiatives
to ensure success in accomplishing the NIH mission, input from partners
and customers is essential. Quality management principles have been
integrated into OER's culture and these surveys will provide customer
satisfaction input on various elements of OER's business processes. The
approximately 14 (10 quantitative and 4 qualitative) customer
satisfaction surveys that will be conducted under this generic
clearance will gather and measure customer and partner satisfaction
with OER processes and operations. The data collected from these
surveys will provide the feedback to track and gauge satisfaction with
NIH's statutorily mandated operations and processes. OER/OD/NIH will
present data and outcomes from these surveys to inform the NIH staff,
officers, leadership, advisory committees, and other decision-making
bodies as appropriate. Based on feedback from these stakeholders, OER/
OD/NIH will
[[Page 70063]]
formulate improvement plans and take action when necessary.
OMB approval is requested for 3 years. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 2,485.
Estimated Annualized Burden Hours
Quantitative Survey
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Number of responses per per response Total annual
respondents respondent (in hours) burden hour
----------------------------------------------------------------------------------------------------------------
Science professionals, applicants, reviewers, 3,820 1 15/60 955
Institutional Officials........................
Adult Science Trainees.......................... 2,000 1 15/60 500
General Public.................................. 4,000 1 15/60 1,000
----------------------------------------------------------------------------------------------------------------
Qualitative Survey
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Number of responses per per response Total annual
respondents respondent (in hours) burden hour
----------------------------------------------------------------------------------------------------------------
Science professionals, applicants, reviewers, 12 1 1 12
Institutional Officials........................
Adult Science Trainees.......................... 6 1 1 6
General Public.................................. 12 1 1 12
----------------------------------------------------------------------------------------------------------------
Dated: November 13, 2013.
Seleda Perryman,
Chief, Project Clearance Officer, Office of Policy for Extramural
Research Administration, National Institutes of Health.
[FR Doc. 2013-27965 Filed 11-21-13; 8:45 am]
BILLING CODE 4140-01-P
